Futura Medical (LON:FUM) Shares Down 5.7% – What’s Next?

Shares of Futura Medical plc (LON:FUM) fell 5.7% on Tuesday . The company traded as low as GBX 0.63 and last traded at GBX 0.63. 1,970,943 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 6,253,206 shares. The stock had previously closed at GBX 0.67.

Futura Medical Price Performance

The business has a fifty day moving average price of GBX 1.03 and a two-hundred day moving average price of GBX 1.21. The firm has a market capitalization of £3.49 million, a price-to-earnings ratio of -0.22 and a beta of 0.01.

Futura Medical (LON:FUM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. The firm had revenue of GBX 170 million during the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. On average, research analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.